أعرض في EDS

TEMPORARY REMOVAL: Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial

التفاصيل البيبلوغرافية
العنوان:	TEMPORARY REMOVAL: Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: Primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
المؤلفون:	N. Harbeck, P.A. Fasching, R. Würstlein, T. Degenhardt, D. Lüftner, R.E. Kates, J. Schumacher, P. Räth, O. Hoffmann, R. Lorenz, T. Decker, M. Reinisch, T. Göhler, P. Staib, O. Gluz, T. Schinköthe, M. Schmidt
المصدر:	Annals of Oncology.
بيانات النشر:	Elsevier BV, 2023.
سنة النشر:	2023
مصطلحات موضوعية:	Oncology, Hematology
تدمد:	0923-7534
DOI:	10.1016/j.annonc.2023.05.003
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::e347079a7593ff0fafbe298fe67889a3 https://doi.org/10.1016/j.annonc.2023.05.003
Rights:	OPEN
رقم الانضمام:	edsair.doi...........e347079a7593ff0fafbe298fe67889a3
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	09237534
DOI:	10.1016/j.annonc.2023.05.003